Introduction
Recombinant Human SBF2/MTMR13 Protein, also known as SET-binding factor 2 (SBF2) or Myotubularin-related protein 13 (MTMR13), is a protein that plays a crucial role in various cellular processes. This protein is produced through recombinant DNA technology, making it a valuable tool for scientific research and potential therapeutic applications.
Structure of Recombinant Human SBF2/MTMR13 Protein
Recombinant Human SBF2/MTMR13 Protein is a 1,443 amino acid protein with a molecular weight of approximately 166 kDa. It contains a phosphatase domain and a SET-binding domain, both of which are essential for its function. The protein is highly conserved across different species, with 98% sequence identity between human and mouse SBF2/MTMR13 protein.
Activity of Recombinant Human SBF2/MTMR13 Protein
Recombinant Human SBF2/MTMR13 Protein is a member of the myotubularin family of proteins, which are known for their phosphatase activity. This protein specifically acts as a dual-specificity phosphatase, meaning it can dephosphorylate both protein and lipid substrates. It has been shown to dephosphorylate phosphatidylinositol 3-phosphate (PI3P) and phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), important signaling molecules involved in cellular processes such as endocytosis and autophagy.
In addition to its phosphatase activity, Recombinant Human SBF2/MTMR13 Protein also plays a role in regulating gene expression. It binds to the SET domain of the histone methyltransferase SETDB1, leading to the repression of gene transcription. This activity has been linked to the development of certain cancers, making SBF2/MTMR13 an important target for cancer research.
Applications of Recombinant Human SBF2/MTMR13 Protein
Recombinant Human SBF2/MTMR13 Protein has a wide range of applications in both basic and applied research. Its ability to dephosphorylate PI3P and PI(3,5)P2 makes it a valuable tool for studying the role of these molecules in cellular processes. Researchers can use this protein to manipulate the levels of these molecules and observe the effects on various cellular pathways.
Furthermore, the role of Recombinant Human SBF2/MTMR13 Protein in gene expression regulation makes it a potential therapeutic target. Studies have shown that mutations in the SBF2/MTMR13 gene are associated with Charcot-Marie-Tooth disease, a neurological disorder. By understanding the function of this protein, researchers can develop targeted therapies for this and other diseases.
Conclusion
Recombinant Human SBF2/MTMR13 Protein is a crucial protein involved in various cellular processes. Its structure and activity make it a valuable tool for scientific research, and its potential therapeutic applications make it a promising target for drug development. Further studies on the function of this protein will continue to advance our understanding of cellular processes and potentially lead to new treatments for diseases.
There are no reviews yet.